Mads G. Jeppesen

Copenhagen, 1360, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Promiscuous binding of CXC chemokines to ORF74 receptors enables immunotoxin approaches in Gammaherpesvirus models.

Promiscuous binding of CXC chemokines to ORF74 receptors enables immunotoxin approaches in Gammaherpesvirus models.

Journal: Biochemical pharmacology

Published: March 03, 2026

Targeting of Kaposi's sarcoma-associated herpesvirus by immunotoxins directed against the viral G protein-coupled receptor, ORF74.

Targeting of Kaposi's sarcoma-associated herpesvirus by immunotoxins directed against the viral G protein-coupled receptor, ORF74.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: August 24, 2025

De novo design of miniproteins targeting GPCRs.

De novo design of miniproteins targeting GPCRs.

Journal: Nature

Published: April 07, 2025

De novo design of miniproteins targeting GPCRs.

De novo design of miniproteins targeting GPCRs.

Journal: Nature

Published: April 07, 2025

Accurate prediction of protein assembly structure by combining AlphaFold and symmetrical docking.

Accurate prediction of protein assembly structure by combining AlphaFold and symmetrical docking.

Journal: Nature communications

Published: June 08, 2023

Publisher Correction: Reply to: How many SARS-CoV-2 "viroporins" are really ion channels?

Publisher Correction: Reply to: How many SARS-CoV-2 "viroporins" are really ion channels?

Journal: Communications biology

Published: September 28, 2022

Reply to: How Many SARS-CoV-2 "Viroporins" Are Really Ion Channels?

Reply to: How Many SARS-CoV-2 "Viroporins" Are Really Ion Channels?

Journal: Communications biology

Published: March 09, 2022

Author Correction: Amantadine inhibits known and novel ion channels encoded by SARS-CoV-2 in vitro.

Author Correction: Amantadine inhibits known and novel ion channels encoded by SARS-CoV-2 in vitro.

Journal: Communications biology

Published: December 11, 2021

Ex vivo treatment of cytomegalovirus in human donor lungs using a novel chemokine-based immunotoxin.

Ex vivo treatment of cytomegalovirus in human donor lungs using a novel chemokine-based immunotoxin.

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Published: June 24, 2021

Amantadine has potential for the treatment of COVID-19 because it inhibits known and novel ion channels encoded by SARS-CoV-2.

Amantadine has potential for the treatment of COVID-19 because it inhibits known and novel ion channels encoded by SARS-CoV-2.

Journal: Communications biology

Published: December 02, 2020

Novel Chemokine-Based Immunotoxins for Potent and Selective Targeting of Cytomegalovirus Infected Cells.

Novel Chemokine-Based Immunotoxins for Potent and Selective Targeting of Cytomegalovirus Infected Cells.

Journal: Journal of immunology research

Published: November 09, 2016

Rationally designed chemokine-based toxin targeting the viral G protein-coupled receptor US28 potently inhibits cytomegalovirus infection in vivo.

Rationally designed chemokine-based toxin targeting the viral G protein-coupled receptor US28 potently inhibits cytomegalovirus infection in vivo.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: June 17, 2015

Showing 1-12 of 12

Last Updated: 09/26/2026